Physician profile
Paul B Tessmann
NPI 1861601833
$4,121.50
in general payments reported to CMS, 2019-2025
7 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,550 · 2020: $449 · 2021: $174 · 2022: $950.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,852.45 | 2019-2022 | |
| Medtronic Vascular, INC. | $1,798.94 | 2019 | |
| Atricure, INC. | $178.79 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $129.93 | 2020 | |
| Baxter Healthcare | $89.91 | 2020 | |
| Abiomed | $49.62 | 2022 | |
| Ethicon US, LLC | $21.86 | 2022 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Tessmann listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.